Childhood asthma—not associated with BCG vaccination

October 2, 2017 by Stéphanie Thibault, Institut national de la recherche scientifique - INRS
Childhood asthma: Not associated with BCG vaccination
Credit: Institut national de la recherche scientifique - INRS

Childhood asthma is a serious public health challenge in Québec and throughout the world. Although the immune mechanisms implicated in the development of childhood asthma are not fully understood, some studies seem to suggest that the BCG vaccine, used in tuberculosis prevention, may have a protective effect on childhood asthma. However there is no consensus and contradictory findings have been reported in other studies.

A research team at the INRS that included professors Marie-Claude Rousseau and Marie-Élise Parent has conducted the largest study on the subject to date. The results? No association was found between the and asthma. The investigation, based on a large sample drawn from the Québec population, was published in the American Journal of Epidemiology.

The team had already compiled data from the registries and archives of the BCG vaccination campaign in Québec from 1956 to 1974, which led to a study previously published in the journal Vaccine. Combining some of these data with several reliable data sources on asthma and using a survey designed to collect information on relevant risk factors, they were able to investigate the presence of any links between BCG vaccination and asthma with a high degree of accuracy.

"It is rare that a vaccination registry covers an entire population," says Marie-Claude Rousseau, "particularly in North America. We are lucky that such a remarkable source of data was preserved here at Centre INRS-Institut Armand Frappier." "Dr. Armand Frappier," she continues, "led the fight against tuberculosis in Québec and saw things from a public health perspective. The data that he gathered and saved for the future are tremendously useful for epidemiological research."

Dr. Rousseau notes that the new study is undoubtedly the largest and most comprehensive ever undertaken to investigate the relationship between BCG vaccination and . It also adjusts for a broad range of confounders—factors that might otherwise distort the findings. The authors conclude that it might be time to look elsewhere for the determinants of and its prevention.

Explore further: Many with work-related asthma not getting key vaccine

More information: Mariam El-Zein et al, Association Between Bacillus Calmette-Guérin Vaccination and Childhood Asthma in the Quebec Birth Cohort on Immunity and Health, American Journal of Epidemiology (2017). DOI: 10.1093/aje/kwx088

Related Stories

Many with work-related asthma not getting key vaccine

September 27, 2017
(HealthDay)—Only half of American adults with work-related asthma get the recommended vaccination against pneumococcal disease, a new study finds.

Researchers shed new light on cancer risks associated with night work

October 15, 2012
Night work can increase cancer risk in men, according to a new study published in the American Journal of Epidemiology by a research team from Centre INRS–Institut Armand-Frappier and Centre de recherche du Centre hospitalier ...

Maternal uncontrolled asthma ups risk of asthma in offspring

July 17, 2017
(HealthDay)—Children whose mothers have uncontrolled asthma during pregnancy are at increased risk of developing the disease at a young age, according to a study published online July 13 in the Journal of Allergy and Clinical ...

Breastfeeding may help prevent children's asthma exacerbations later in life

September 1, 2017
In a Pediatric Allergy and Immunology analysis of children with asthma, those who had been breastfed had a 45 percent lower risk of asthma exacerbations later in life compared with children who had not been breastfed.

Are childhood asthma rates declining?

January 12, 2016
Childhood asthma has made headlines in recent years because of an upward trend in the number of cases. That may have changed: A government study published in the journal Pediatrics shows asthma rates may be leveling off or ...

Recommended for you

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

Eczema drug restores hair growth in patient with longstanding alopecia

October 10, 2018
Massachusetts General Hospital (MGH) physicians are reporting an unexpected side-effect from treatment with dupilumab, which is FDA approved for the treatment of moderate to severe eczema, also called atopic dermatitis. In ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.